BULLETIN V2025-4052
NERVGEN PHARMA CORP. ("NGEN")
BULLETIN TYPE: Warrant Price Amendment
BULLETIN DATE: December 15, 2025
TSX Venture Tier 2 Company
TSX Venture Exchange has consented to the increase in the exercise price of the following warrants:
Private Placement:
# of Warrants: 5,075,000
Expiry Date of Warrants: July 13, 2027
Original Exercise Price of Warrants: US$1.75
New Exercise Price of Warrants: C$2.44
These warrants were issued pursuant to a private placement of 10,150,000 shares with 5,075,000 share purchase warrants attached, which was accepted for filing by the Exchange effective July 15, 2022.
_______________________________________
|
|
